Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Chirik Wah Lau"'
Autor:
Monika Kobediona, MD, Jozef Bartunek, MD, PhD, Leen Delrue, PhD, Frederik Van Durme, MD, Chirik Wah Lau, MD, Ana Moya, PhD, Sofie Verstreken, MD, Ward Heggermont, MD, PhD, Riet Dierckx, MD, Marc Goethals, MD, Marc Vanderheyden, MD
Publikováno v:
Transplantation Direct, Vol 8, Iss 6, p e1336 (2022)
Background. A pulmonary capillary wedge pressure (PCWP) >18 mm Hg following volume load has been proposed as a partition value for the detection of heart failure with preserved ejection fraction. As hemodynamic changes in filling pressures (FP) have
Externí odkaz:
https://doaj.org/article/84e242fa2dca41959f1a6eec4fd4d185
Publikováno v:
Case Reports in Cardiology, Vol 2020 (2020)
We present a patient with severe nonischemic cardiomyopathy in whom the HeartLogic algorithm was activated on her Boston Scientific cardioverter defibrillator. She had an out-of-alert state for several months and had clinically “stable” heart fai
Externí odkaz:
https://doaj.org/article/b5356c81dab94abfab85093a8cc5e6ee
Autor:
Marnix J. von Kemp, Vincent Floré, Chirik Wah Lau, Johan De Sutter, Frank Provenier, Kristoff Cornelis
Publikováno v:
Acta Cardiologica. 77:922-929
BACKGROUND: Stroke is a major concern in transcatheter aortic valve replacement (TAVR). The introduction of a cerebral protection devices may counteract the evolution towards minimally invasive TAVR. At this time, there is insufficient data to suppor
Autor:
Jos Backers, Willy Timmermans, Ward Heggermont, Jan De Cooman, Koen Van Bockstal, Tom De Potter, Chirik-Wah Lau, Dieter Missiaen, Konstantinos Iliodromitis, Peter Geelen
Publikováno v:
Pacing and Clinical Electrophysiology, 44(5), 943-951. Wiley
Background Exercise capacity is an important aspect of quality of life in patients undergoing pacemaker implantation. Device algorithms for ventricular pacing avoidance have been developed to avoid unnecessary and potentially harmful effects of right
Publikováno v:
Clinical Cardiology and Cardiovascular Interventions. 3:01-07
Cardiac angiosarcomas are rare malignant tumors, predominantly affecting the right heart with poor survival outcomes. The current mainstay of treatment consists of surgery with or without chemotherapy, but often yields limited results with local rela
Publikováno v:
Acta Cardiologica. 74:405-412
Background: Sacubitril/valsartan significantly reduced heart failure(HF) hospitalisations and mortality in the PARADIGM-HF-trial. However real-world data on symptomatic and functional improvement are lacking. Methods: Between December 2016 and Januar
Publikováno v:
Case reports in cardiology, 2020:8896152. Hindawi Publishing Corporation
Case Reports in Cardiology, Vol 2020 (2020)
Case reports in cardiology, 2020:8896152
CASE REPORTS IN CARDIOLOGY
Case Reports in Cardiology
Case Reports in Cardiology, Vol 2020 (2020)
Case reports in cardiology, 2020:8896152
CASE REPORTS IN CARDIOLOGY
Case Reports in Cardiology
We present a patient with severe nonischemic cardiomyopathy in whom the HeartLogic algorithm was activated on her Boston Scientific cardioverter defibrillator. She had an out-of-alert state for several months and had clinically "stable" heart failure
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::888ac16d958cfc7ff3ea2e22765effc9
https://cris.maastrichtuniversity.nl/en/publications/c2a3d60d-d8f1-4937-9668-da6733abfe8d
https://cris.maastrichtuniversity.nl/en/publications/c2a3d60d-d8f1-4937-9668-da6733abfe8d
Sacubitril/valsartan reduced heart failure (HF)-admissions and cardiovascular mortality in the PARADIGM-HF-trial. However, real-world patients are often frailer and less able to tolerate high doses of sacubitril/valsartan.We performed a retrospective
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::01c3fa6a1502a29150684a56e905c0d1